aceArtificial Intelligence Across the Pharmaceutical Life Cycle: Implications for Industry-Based Clinical Pharmacists
Artificial intelligence (AI) is increasingly shaping the pharmaceutical industry. This ACCP commentary examines the implications of AI for industry-based clinical pharmacists across the pharmaceutical life cycle, including drug development, regulatory affairs, medical affairs, health economics and outcomes research, and pharmacovigilance. Artificial intelligence-enabled tools may support target identification, clinical trial design, regulatory intelligence, evidence synthesis, medical content generation, real-wo…
AI-enabled tools may support pharmaceutical functions including target identification, trial design, regulatory intelligence, evidence synthesis, and safety signal detection, expanding reach and efficiency.
AI implementation in pharmaceutical industry functions introduces important risks and practical implementation challenges requiring human oversight.
Evidence
- Peer-reviewedJACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY2026-10-01
How should this claim be treated?
Truvace Impact Record TRV-2026-1246, v1: “Artificial Intelligence Across the Pharmaceutical Life Cycle: Implications for Industry-Based Clinical Pharmacists.” Truvace, 2026-10-02. /record/TRV-2026-1246 (accessed at citation time). sha256 debe69e12c1dc3f8…
Calibration history
Every change to this record since certification, in the open. None yet — the reading has held since it entered the record.
Certified into the record
How to verify without trusting this page
Fetch the canonical text of any version from /api/record/TRV-2026-1246 and hash it yourself — for example shasum -a 256 on the saved canonical field. The result must equal content_hash, and each version’s text ends with prev:followed by the prior version’s hash (version 1 chains to 64 zeros). If a single character of any version had been altered since certification, the chain would not reproduce.